SCHEMBL3658428

SCHEMBL3658428

Cc1ccc(CC(N)=O)c(C(N)=O)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ICMT O60725 3/20 0.44
SRC P12931 1/20 0.42
PARP1 P09874 1/20 0.41
CSNK2A1 P68400 1/20 0.41
MAPK8 P45983 3/20 0.41
HTT P42858 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CA2 P00918 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK10 P53779 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAP2K2 P36507 1/20 0.38
MAP2K1 Q02750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653927 0.83 P2RX7 (0.47) ICMTSRCMAPK8HTTCA2
SCHEMBL31481088 0.83 P2RX7 (0.47) ICMTSRCMAPK8HTTCA2
SCHEMBL24102357 0.82 PARP1 (0.47) SRCPARP1CSNK2A1MAPK8HTT
SCHEMBL2702114 0.82 ICMT (0.45) ICMTSRCHTTMEN1KMT2A
SCHEMBL28254697 0.81 ICMT (0.44) ICMTSRCHTTCA2RAB9A
SCHEMBL1354273 0.81 ALDH1A1 (0.45) ICMTSRCHTTCA2SMN1; SMN2
SCHEMBL28188707 0.79 ICMT (0.43) ICMTSRCHTTKMT2ACA2
SCHEMBL25382106 0.79 ICMT (0.43) ICMTSRCHTTNPC1HPGD
SCHEMBL30570712 0.78 TAAR1 (0.52) ICMTSRCHTTMEN1KMT2A
SCHEMBL1478491 0.78 TAAR1 (0.52) ICMTSRCHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234966-A2 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY Sanofi-Aventis (FR) 2010-10-06 EP disclosed
WO-2009106708-A2 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI-AVENTIS (FR) 2009-09-03 WO disclosed